CCR3, NT, Control Peptide (CD193, CC Chemokine Receptor Type 3, CC CKR 3, CC CKR3, B Chemokine Receptor, CMKBR3, Eosinophil CC Chemokine Receptor 3, Eosinophil Eotaxin Receptor, MGC102841)

Cat# C2099-67G1-50ug

Size : 50ug

Brand : US Biological

Request more information

Contact local distributor :


Phone : +1 850 650 7790


C2099-67G1 CCR3, NT, Control Peptide (CD193, CC Chemokine Receptor Type 3, CC CKR 3, CC CKR3, B Chemokine Receptor, CMKBR3, Eosinophil CC Chemokine Receptor 3, Eosinophil Eotaxin Receptor, MGC102841)

Clone Type
Polyclonal
Grade
Purified
Applications
WB
Shipping Temp
Blue Ice
Storage Temp
-20°C

Synthetic peptide, CCR3, 14 aa, near the amino terminus of human CCR3 (Genbank accession No. NP_847899).||Applications: |Suitable for use in Antibody Blocking. Other applications not tested.||Recommended Dilution:|1-2ug/ml; blocks C2099-67G activity completely by incubating the peptide with equal volume of antibody for 30 min at 37°C.|Optimal dilutions to be determined by the researcher.||Storage and Stability:|May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing.. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Applications
Source: Synthetic peptide, CCR3, 14 aa, near the amino terminus of human CCR3 (Genbank accession No. NP_847899).|Purity: Purified|Concentration: ~0.2mg/ml|Form: Supplied as a liquid in PBS, pH 7.2, 0.1% BSA, 0.02% sodium azide.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Form
Supplied as a liquid in PBS, pH 7.2, 0.1% BSA, 0.02% sodium azide.
Purity
Purified
References
1. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85:1135-48.